Press Releases | Medtronic

Month Year

Email alerts

Jun 15, 2018

Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons

GLOBE NEWSWIRE via COMTEX) --New, Extended Balloon Lengths Enable Physicians to Efficiently Treat Long SFA Lesions DUBLIN - June 15, 2018 - Medtronic plc (NYSE: MDT) today announced that it has...
Jun 1, 2018

FDA Classifies HeartWare(TM) HVAD(TM) Systems Unexpected Power Source Switching as Class I Recall

DUBLIN - June 1, 2018 - The United States Food and Drug Administration (FDA) has classified Medtronic plc's (NYSE: MDT) recent voluntary urgent field action related to the HeartWare(TM) HVAD(TM)...
May 24, 2018

Independent Stent Imaging Study Shows Excellent Healing Profile with Resolute Onyx DES in Complex Patients with Coronary Artery Disease

Onyx 1-Month OCT Study Provides Potential Insights on DAPT Duration in Complex Patients Following Stent Implantation

DUBLIN and PARIS- May 24, 2018 - Investigators today unveiled clinical data from the independently run Onyx 1-Month OCT Study, which showed strong early vessel healing in a patient population that...
May 23, 2018

New Medtronic Data Show Significant Blood Pressure Lowering Effect of Renal Denervation in Patients Taking Anti-Hypertensive Medication

Late-Breaking SPYRAL HTN-ON MED Study at EuroPCR Indicates RDN Lowers Blood Pressure in Hypertensive Patients in Presence of BP Medication

DUBLIN and PARIS - May 23, 2018 - Medtronic plc (NYSE:MDT) today announced first-ever-data from the SPYRAL HTN-ON MED Study. Initial study results found statistically significant and clinically...
May 16, 2018

Medtronic Begins U.S. Study of Drug-Eluting Stents to Evaluate Treatment of Bifurcation Lesions in Patients with Coronary Artery Disease

Medtronic Received IDE Approval from FDA to Generate Clinical Evidence with Resolute Onyx DES to Support Future Application for Expanded Indication in U.S.

DUBLIN - May 16, 2018 - Medtronic plc (NYSE: MDT) today announced the initiation of a clinical study in the U.S. to assess the safety and efficacy of drug-eluting stents (DES) for the treatment of...
May 15, 2018

New Analysis Shows Medtronic Cardiac Resynchronization Therapy Feature Associated with Improved Patient Survival

Real-World Data on AdaptivCRT(TM) Algorithm Presented at Heart Rhythm 2018

DUBLIN - May 15, 2018 - Medtronic plc (NYSE: MDT) announced study results showing its exclusive AdaptivCRT(TM) algorithm is associated with improved patient survival. The data were recently...
May 11, 2018

Medtronic Study Confirms Feasibility of New Extravascular Approach to ICD Therapy

Late-Breaking Presentation at Heart Rhythm 2018 Highlights Investigational Experience with ICD Lead Placed Under Sternum, Outside the Heart and Veins

DUBLIN and BOSTON - May 11, 2018 - Medtronic plc (NYSE:MDT) today announced results from a research study demonstrating the feasibility of a novel approach to delivering pacing and defibrillation...
May 11, 2018

New Study Demonstrates Feasibility of Novel Mechanical Sensor in Medtronic Micra Transcatheter Pacing System to Detect Atrial Contractions and Restore AV Synchrony

Late-Breaking Presentation at Heart Rhythm 2018 Shows Potential for More Patients to Benefit from World's Smallest Pacemaker

DUBLIN and BOSTON - May 11, 2018 - Medtronic plc (NYSE:MDT) today announced new clinical study results demonstrating that an investigational algorithm, utilizing the accelerometer signal in the...
May 9, 2018

Data Reinforce Reduced Complications with Medtronic Micra Transcatheter Pacing System Over Traditional Pacemakers in Real-World Use

Results Presented at Heart Rhythm 2018 Also Show Leadless Pacemaker is Safe Option for Patients with Past Device Infection

DUBLIN and BOSTON - May 9, 2018 - Medtronic plc (NYSE: MDT) today announced that results through 12-months from the Post-Approval Registry (PAR) for the Medtronic Micra(TM) Transcatheter Pacing...
Apr 26, 2018

Two-Year Feasibility Study Results Encouraging with Medtronic Harmony(TM) Transcatheter Pulmonary Valve

DUBLIN and SAN DIEGO - April 26, 2018 - Medtronic plc (NYSE: MDT) today announced two-year outcomes for the Harmony(TM) Transcatheter Pulmonary Valve (TPV) from its early feasibility study....

Show per page